反応式
[CH2:1]([C:4]1[N:5]=[N:6][N:7]([CH2:9][C:10]([N:12]2[CH2:17][CH2:16][O:15][CH:14]([C:18]([OH:20])=O)[CH2:13]2)=[O:11])[CH:8]=1)[CH2:2][CH3:3].[Li].[NH2:22][C@@H:23]([CH2:41][C:42]1[CH:47]=[CH:46][CH:45]=[CH:44][CH:43]=1)[C@H:24]([OH:40])[CH2:25][NH:26][C@@H:27]1[C:36]2[C:31](=[CH:32][CH:33]=[C:34]([Br:37])[CH:35]=2)[O:30][C:29]([CH3:39])([CH3:38])[CH2:28]1.[CH3:48]N(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F>CN(C=O)C>[Br:37][C:34]1[CH:35]=[C:36]2[C:31](=[CH:32][CH:33]=1)[O:30][C:29]1([CH2:39][CH2:48][CH2:38]1)[CH2:28][C@@H:27]2[NH:26][CH2:25][C@@H:24]([OH:40])[C@@H:23]([NH:22][C:18]([C@@H:14]1[O:15][CH2:16][CH2:17][N:12]([C:10](=[O:11])[CH2:9][N:7]2[CH:8]=[C:4]([CH2:1][CH2:2][CH3:3])[N:5]=[N:6]2)[CH2:13]1)=[O:20])[CH2:41][C:42]1[CH:47]=[CH:46][CH:45]=[CH:44][CH:43]=1参加物
6
反応物 4
生成物 1
試薬・触媒・溶媒 1
実験手順
In a 15-mL RBF, the 4-(2-(4-propyl-1H-1,2,3-triazol-1-yl)acetyl)morpholine-2-carboxylic acid (0.034 g, 0.11 mmol) as the crude lithium salt and (2R,3S)-3-amino-1-((S)-6-bromo-2,2-dimethylchroman-4-ylamino)-4-phenylbutan-2-ol (0.046 g, 0.11 mmol) were taken up in DMF (1.5 mL). When the solids had dissolved, HATU (0.041 g, 0.11 mmol) was added. After 14 h, the reaction was concentrated, and the residue was taken up in EtOAc (60 mL) and the organic layer was extracted with water (5 mL), dried over sodium sulfate and concentrated. The residue was purified through silica gel (15 mL) which had been deactivated with TEA (2.0 mL) eluting with 4% MeOH-EtOAc, to afford the title compound as a 1:1 mixture of diastereomers. MS m/z 695/697 (M+1).
後処理
- dissolutionWhen the solids had dissolved
- concentrationthe reaction was concentrated
- extractionthe organic layer was extracted with water (5 mL)
- dry with materialdried over sodium sulfate
- concentrationconcentrated
- customThe residue was purified through silica gel (15 mL) which
- washeluting with 4% MeOH-EtOAc
出典と根拠
- ORDレコード
- ord-3d10066892cb490d890fafe962ab9915
- 出典データセット
- uspto-grants-2011_01
- 特許番号
- US07872009B2
関連ノート
読み込み中…